These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28951797)

  • 21. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decision under risk: Argument against early deep brain stimulation in Parkinson's disease.
    Kim HJ; Jeon B
    Parkinsonism Relat Disord; 2019 Dec; 69():7-10. PubMed ID: 31634692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
    Tramontana MG; Molinari AL; Konrad PE; Davis TL; Wylie SA; Neimat JS; May AT; Phibbs FT; Hedera P; Gill CE; Salomon RM; Wang L; Song Y; Charles D
    J Parkinsons Dis; 2015; 5(1):151-63. PubMed ID: 25613351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better.
    Mestre TA; Espay AJ; Marras C; Eckman MH; Pollak P; Lang AE
    Mov Disord; 2014 Dec; 29(14):1751-6. PubMed ID: 25227325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's Disease: Surgical Options.
    Bronte-Stewart H
    Curr Treat Options Neurol; 2003 Mar; 5(2):131-147. PubMed ID: 12628062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation.
    Blomstedt P; Stenmark Persson R; Hariz GM; Linder J; Fredricks A; Häggström B; Philipsson J; Forsgren L; Hariz M
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):710-716. PubMed ID: 29386253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep Brain Stimulation in Parkinson's Disease.
    Malek N
    Neurol India; 2019; 67(4):968-978. PubMed ID: 31512617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Deep brain stimulation for Parkinson's disease and dystonia].
    Yokochi F
    Brain Nerve; 2009 Apr; 61(4):473-83. PubMed ID: 19378817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of deep brain stimulation as a surgical treatment for Parkinson's disease.
    Olanow CW; Brin MF; Obeso JA
    Neurology; 2000; 55(12 Suppl 6):S60-6. PubMed ID: 11188977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining cell transplants or gene therapy with deep brain stimulation for Parkinson's disease.
    Rowland NC; Starr PA; Larson PS; Ostrem JL; Marks WJ; Lim DA
    Mov Disord; 2015 Feb; 30(2):190-5. PubMed ID: 25521796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.
    Alberts JL; Voelcker-Rehage C; Hallahan K; Vitek M; Bamzai R; Vitek JL
    Brain; 2008 Dec; 131(Pt 12):3348-60. PubMed ID: 18842609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous apomorphine in advanced Parkinson's disease patients treated with deep brain stimulation.
    Sesar Á; Fernández-Pajarín G; Ares B; Relova JL; Arán E; Rivas MT; Gelabert-González M; Castro A
    J Neurol; 2019 Mar; 266(3):659-666. PubMed ID: 30617907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and anxiety following deep brain stimulation in Parkinson's disease: systematic review and meta-analysis.
    Couto MI; Monteiro A; Oliveira A; Lunet N; Massano J
    Acta Med Port; 2014; 27(3):372-82. PubMed ID: 25017350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on Deep Brain Stimulation and Its Earlier Use for Parkinson's Disease: A Qualitative Study of US Patients.
    Cabrera LY; Kelly-Blake K; Sidiropoulos C
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31936218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep brain stimulation for Parkinson's disease and other movement disorders.
    Kalia SK; Sankar T; Lozano AM
    Curr Opin Neurol; 2013 Aug; 26(4):374-80. PubMed ID: 23817213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Neuromodulatory Impact of Subthalamic Nucleus Deep Brain Stimulation on Gait and Postural Instability in Parkinson's Disease Patients: A Prospective Case Controlled Study.
    Szlufik S; Kloda M; Friedman A; Potrzebowska I; Gregier K; Mandat T; Przybyszewski A; Dutkiewicz J; Figura M; Habela P; Koziorowski D
    Front Neurol; 2018; 9():906. PubMed ID: 30429820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.